From October 1, 2023 to January 1, 2024, the company has repurchased 3,014,355 shares, representing 5.93% for $30.43 million. With this, the company has completed the repurchase of 31,414,836 shares, representing 49.07% for $325 million under the buyback announced on September 19, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.49 USD | -0.52% | +7.35% | -15.57% |
04-12 | Sector Update: Health Care Stocks Lower Friday Afternoon | MT |
04-12 | Theravance Biopharma Shares Rise After BTIG Starts Coverage at Buy | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.57% | 461M | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+15.85% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B |
- Stock Market
- Equities
- TBPH Stock
- News Theravance Biopharma, Inc.
- Tranche Update on Theravance Biopharma, Inc.'s Equity Buyback Plan announced on September 19, 2022.